NCT05632744View on ClinicalTrials.gov

Evaluation of CG-100 Intraluminal Bypass Device

NARecruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

June 15, 2024

Study Completion Date

June 15, 2024

Conditions

Colorectal Cancer

Interventions

DEVICE

CG-100 Intraluminal Bypass Device

Subjects will be treated with the CG-100 Intraluminal Bypass Device

Trial Locations (1)

Unknown

RECRUITING

Soroka Medical Center, Rehovot

All Listed Sponsors

lead

Colospan Ltd.

INDUSTRY